Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 60 citing articles:

Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Jamie Burgess, Maryam Ferdousi, David Gosal, et al.
Oncology and Therapy (2021) Vol. 9, Iss. 2, pp. 385-450
Open Access | Times Cited: 177
Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment
Raymond C. Tait, Kim Zoberi, McKenzie Ferguson, et al.
Journal of Pain (2018) Vol. 19, Iss. 12, pp. 1367-1383
Open Access | Times Cited: 153
Quality of Life in Painful Peripheral Neuropathies: A Systematic Review
Ayesha Girach, Thomas Julian, Giustino Varrassi, et al.
Pain Research and Management (2019) Vol. 2019, pp. 1-9
Open Access | Times Cited: 134
Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
Kinga Sałat
Pharmacological Reports (2020) Vol. 72, Iss. 3, pp. 508-527
Open Access | Times Cited: 87
Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Jessica N. Mezzanotte, Michael Grimm, Namrata Vilas Shinde, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 1, pp. 29-42
Open Access | Times Cited: 43
Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool
Nara Lins Meira Quintão, José Roberto Santin, Luis Carlos Stoeberl, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 68
Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB
Jing Meng, Qiuyan Zhang, Chao Yang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 61
Vinca alkaloids, thalidomide and eribulin‐induced peripheral neurotoxicity: From pathogenesis to treatment
Badrul Islam, Maryam B. Lustberg, Nathan P. Staff, et al.
Journal of the Peripheral Nervous System (2019) Vol. 24, Iss. S2
Closed Access | Times Cited: 59
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
Yang Yang, Bing Zhao, Xuejiao Gao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 48
Maximizing treatment efficacy through patient stratification in neuropathic pain trials
Ralf Baron, Anthony H. Dickenson, Margarita Calvo, et al.
Nature Reviews Neurology (2022) Vol. 19, Iss. 1, pp. 53-64
Closed Access | Times Cited: 33
Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
Guido Cavaletti, P Marmiroli
Cancers (2020) Vol. 12, Iss. 6, pp. 1370-1370
Open Access | Times Cited: 48
The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy
Cindy Tofthagen, Andrea Cheville, Charles L. Loprinzi
Current Oncology Reports (2020) Vol. 22, Iss. 5
Closed Access | Times Cited: 39
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Multicenter, Pilot, Randomized, Wait-List Controlled Trial
Robert Knoerl, Elizabeth Smith, Debra L. Barton, et al.
Journal of Pain (2017) Vol. 19, Iss. 4, pp. 382-394
Open Access | Times Cited: 48
Comparison of clinical characteristics of post-refractive surgery-related and post-herpetic neuropathic corneal pain
Betül Bayraktutar, Mehmet Cüneyt Özmen, Nasser Muzaaya, et al.
The Ocular Surface (2020) Vol. 18, Iss. 4, pp. 641-650
Open Access | Times Cited: 28
Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy
Avallone Antonio, Sabrina Bimonte, Claudia Cardone, et al.
Anticancer Research (2022) Vol. 42, Iss. 10, pp. 4667-4678
Open Access | Times Cited: 17
Multi-Disciplinary Management in Rectal Cancer Survivorship: A Clinical Practice Review
Hilary Chan, Marissa B. Savoie, Amir Munir, et al.
Journal of Gastrointestinal Cancer (2023) Vol. 54, Iss. 4, pp. 1102-1115
Open Access | Times Cited: 9
Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Narrative Review and Proposed Theoretical Model
Kimberley Lee, Hailey W. Bulls, Aasha I. Hoogland, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2571-2571
Open Access | Times Cited: 3
Cancer survivors and return to work: current knowledge and future research
Saskia F. A. Duijts, Susanne Oksbjerg Dalton, Marie Høyer Lundh, et al.
Psycho-Oncology (2016) Vol. 26, Iss. 5, pp. 715-717
Closed Access | Times Cited: 26
Chemotherapy-induced peripheral neuropathy
Peggy Y. Kim, Carrie E. Johnson
Current Opinion in Anaesthesiology (2017) Vol. 30, Iss. 5, pp. 570-576
Closed Access | Times Cited: 26
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin
Lorenzo Di Cesare Mannelli, Mario Maresca, Laura Micheli, et al.
Cancer Chemotherapy and Pharmacology (2017) Vol. 80, Iss. 6, pp. 1091-1103
Closed Access | Times Cited: 25
Estimating the Frequency, Severity, and Clustering of SPADE Symptoms in Chronic Painful Chemotherapy-Induced Peripheral Neuropathy
Robert Knoerl, Zach Chornoby, Elizabeth Smith
Pain Management Nursing (2018) Vol. 19, Iss. 4, pp. 354-365
Open Access | Times Cited: 19
Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy
Grace Kanzawa-Lee, Robert Knoerl, Clare Donohoe, et al.
Seminars in Oncology Nursing (2019) Vol. 35, Iss. 3, pp. 253-260
Open Access | Times Cited: 18
Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials
Chenkun Wang, Si Chen, Weiwei Jiang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Prevention and therapy of chemotherapy-induced peripheral neuropathy: a review of recent findings
Zuzana Michalová, Eva Székiová, Juraj Blaško, et al.
Neoplasma (2022) Vol. 70, Iss. 01, pp. 15-35
Open Access | Times Cited: 9
Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience
Roser Velasco, Sarah Besora, Andreas A. Argyriou, et al.
Anti-Cancer Drugs (2020) Vol. 32, Iss. 1, pp. 88-94
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top